CIK 0001563665 · Non-accelerated filer<br>Smaller reporting company
Harvard Apparatus Regenerative Technology, Inc.
Sign in to watch- Ticker
- HRGN
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 455210462
- Phone
- (774) 233-7300
- Business address
- 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746
- Former names
- Biostage, Inc.
- Open-market buys, last 90 days
- $394,459
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$394,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-27 | GREEN DAVID Director | Grant or award · Stock Option (right to buy) | +10,204 | 10,204 | ||
| 2024-06-27 | GREEN DAVID Director | Grant or award · Stock Option (right to buy) | +8,215 | 8,215 | ||
| 2024-06-27 | Chen Jing Director | Grant or award · Stock Option (right to buy) | +10,204 | 10,204 | ||
| 2024-06-27 | Chen Jing Director | Grant or award · Stock Option (right to buy) | +8,215 | 8,215 | ||
| 2024-06-21 | He Junli CEO | Purchase | +1,600 | $2.80 | $4K | 254,600 |
| 2024-01-11 | He Junli CEO | Grant or award · Stock Option (right to buy) | +220,640 | 220,640 | ||
| 2023-12-27 | He Junli CEO | Purchase | +2,700 | $4.76 | $13K | 253,000 |
| 2023-12-14 | He Junli CEO | Purchase | +900 | $4.92 | $4K | 250,300 |
| 2023-12-06 | He Junli CEO | Purchase | +1,500 | $5.07 | $8K | 249,400 |
| 2023-09-11 | He Junli CEO | Purchase | +1,500 | $5.43 | $8K | 247,900 |
| 2023-08-28 | He Junli CEO | Purchase | +3,400 | $4.69 | $16K | 246,400 |
| 2023-08-21 | Shmerling James E. Director | Purchase | +6,864 | $4.35 | $30K | 23,756 |
| 2023-08-18 | He Junli CEO | Purchase | +8,000 | $4.32 | $35K | 243,000 |
| 2023-07-26 | Chen Jing Director | Grant or award · Stock Option (right to buy) | +7,269 | 7,269 | ||
| 2023-07-26 | Chen Jing Director | Grant or award · Stock Option (right to buy) | +5,819 | 5,819 | ||
| 2023-07-26 | Li Ting Director | Grant or award · Stock Option (right to buy) | +7,269 | 7,269 | ||
| 2023-07-26 | Li Ting Director | Grant or award · Stock Option (right to buy) | +5,819 | 5,819 | ||
| 2023-07-26 | Sanchez Herman Director | Grant or award · Stock Option (right to buy) | +7,269 | 7,269 | ||
| 2023-07-26 | Sanchez Herman Director | Grant or award · Stock Option (right to buy) | +5,819 | 5,819 | ||
| 2023-07-26 | Shmerling James E. Director | Grant or award · Stock Option (right to buy) | +7,269 | 7,269 |
Page 3 of 10 · 182 trades